bibibi.ccLoading…
Moderna The stock price once fell 10%, with the cumulative decline over days reaching 26%。
Moderna The stock price once fell 10%BlockBeats reported that October 23, according to BIT(bit.com) market data,Moderna the stock price once fell 10%, with the cumulative decline over days reaching 26%.
As previously reported, the personalized melanoma vaccine jointly developed by Moderna (Moderna) and Merck had its Phase data leaked prematurely. Despite positive clinical results, the stock was still heavily sold off.
Original link https://m.theblockbeats.info/flash/373434
according to BIT market data,Moderna the stock price once fell 10%。
Moderna the cumulative decline in the stock price over days reached 26%。
Previous reports mentioned that Moderna the Phase data for the personalized melanoma vaccine jointly developed with Merck was leaked prematurely.
Reports relayed that the relevant clinical results were positive, but the stock was still heavily sold off.
The following is analysis, separate from reported facts. Verify important claims independently.
This news mainly discusses Moderna a substantial decline in the stock price and mentions the premature leak of Phase data for a vaccine developed in cooperation with Merck.
It presents both the stock price decline and the reporting context of the related clinical data leak, but the specific relationship between the two still requires confirmation from more formal information.
Beginners can first distinguish between the “intraday decline at one point” and the “cumulative decline over days,” and note that a report relayed by another source is not equivalent to an official company announcement.
Loading event timeline…
This term is not in the glossary yet. Browse related concepts in the glossary.
View glossary →This term is not in the glossary yet. Browse related concepts in the glossary.
View glossary →This term is not in the glossary yet. Browse related concepts in the glossary.
View glossary →